Why is Bal Pharma falling/rising?

As of 03-Sep, Bal Pharma Ltd's stock price is currently at Rs 89.14, reflecting a decline of Rs 1.86 or 2.04%. Today's price summary indicates that the stock opened with a gain of 4.84% but has since fallen, marking a trend reversal after three consecutive days of gains. The stock has shown high volatility today, with an intraday range between Rs 89.05 and Rs 95.4. Over the past week, the stock has outperformed the Sensex with a return of +1.87%, but it has significantly underperformed over the longer term, with a year-to-date decline of -27.08% compared to the Sensex's +3.11%. The company has faced challenges, including a negative return of -32.55% over the past year and declining profits, which have fallen by -5.4%. Additionally, the stock's weak long-term fundamentals, including a low Return on Capital Employed (ROCE) and poor debt servicing ability, contribute to its recent price movement.
Broader Market Context: In the context of the broader market, Bal Pharma's recent performance contrasts sharply with the Sensex, which has shown resilience with a slight positive return over the same periods. While the stock has experienced a short-term uptick, its overall trajectory remains negative, with consistent underperformance against the benchmark over the last three years. The market sentiment appears to be cautious, influenced by the company's negative results in the last three quarters and its inability to generate sustainable growth, which has led to a lack of investor confidence.